During the past decade, Hospital Moisès Broggi conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 8 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 8 clinical trials were completed. i.e. 34.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Moisès Broggi" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau" with 3 trials sponsored, "Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa" with 3 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 3 trials sponsored and "MedSIR" with 3 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Moisès Broggi" #1 collaborator was "Instituto de Salud Carlos III" with 4 trials as a collaborator, "Hospital Clinic of Barcelona" with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "Complejo Hospitalario de Navarra" with 2 trials as a collaborator and "Hospital Universitario La Paz" with 2 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Moisès Broggi" are "Multiple Sclerosis" (5 trials), "Atrial Fibrillation" (4 trials), "Colorectal Cancer" (3 trials), "Perioperative Care" (3 trials) and "Postoperative Complications" (3 trials). Many other conditions were trialed in "Hospital Moisès Broggi" in a lesser frequency.

Most popular intervention types in "Hospital Moisès Broggi" are "Drug" (36 trials), "Procedure" (9 trials), "Other" (5 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Hydroxychloroquine" (2 trials), "Mavenclad®" (2 trials), "Methylprednisolone" (2 trials) and "Panitumumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Moisès Broggi" are 55 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Moisès Broggi". undefined are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Hospital Moisès Broggi, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Moisès Broggi, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 5 trials that are defined as “Not Applicable".